CYP24A1 and colorectal carcinoma: Here, we showed that MDL-811 may induce the transcriptional repression of CYP24A1 through the activation of SIRT6 deacetylation; thus, we rationally established a combination therapy approach to increase the sensitivity of CRC to VD3 therapy by the addition of the SIRT6 activator MDL-811.